Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study have?
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study has 170 citations in the OpenAlex counts ScholarIQ stores.
When was Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study published?
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study has 2021 year in the ScholarIQ index.
What is the open-access status of Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study?
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study has hybrid oa status in the ScholarIQ index.
What is the DOI of Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study?
The DOI for Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study is on the source record.
What is the PMID of Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study?
The PMID for Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study is on the source record.
What is the OpenAlex record for Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study?
The OpenAlex for Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study is on the source record.